BioHarvest Sciences Inc. reiterated its sales orders guidance for 2022. The company reiterated its 2022 sales orders guidance of USD 5 million - USD 7 million representing a 2.5 times - 3.5 times growth over 2021.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.4 CAD | 0.00% | +3.07% | +11.63% |
1st Jan change | Capi. | |
---|---|---|
+11.63% | 102M | |
+12.97% | 8.1B | |
+3.37% | 7.57B | |
-15.13% | 5B | |
-9.22% | 3.57B | |
-19.61% | 3.2B | |
-12.98% | 1.19B | |
-31.03% | 1.06B | |
-15.13% | 867M | |
-10.31% | 861M |
- Stock Market
- Equities
- BHSC Stock
- News BioHarvest Sciences Inc.
- BioHarvest Sciences Inc. Reiterates Sales Orders Guidance for 2022